CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Activities Report & Appendix 4C, page-13

  1. 229 Posts.
    lightbulb Created with Sketch. 55
    As stated previously, the all important figures will be this time next year with a large amount of products being launched Q4 giving all revenue streams a chance to establish and grow. Would have been nice to see a bit more traction early on but no dramas IMO - plenty in the pipeline.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.